| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3357633
Max Phase: Preclinical
Molecular Formula: C19H22BrN5O4
Molecular Weight: 464.32
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cn1c(COC(=O)N2CCC[C@H]2C(=O)NC[C@@H]2CC(Br)=NO2)nc2ccccc21
Standard InChI: InChI=1S/C19H22BrN5O4/c1-24-14-6-3-2-5-13(14)22-17(24)11-28-19(27)25-8-4-7-15(25)18(26)21-10-12-9-16(20)23-29-12/h2-3,5-6,12,15H,4,7-11H2,1H3,(H,21,26)/t12-,15-/m0/s1
Standard InChI Key: HPDUTSBWPGOWHZ-WFASDCNBSA-N
Associated Targets(Human)
Protein-glutamine gamma-glutamyltransferase K 164 Activities
Protein-glutamine gamma-glutamyltransferase 1221 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 464.32 | Molecular Weight (Monoisotopic): 463.0855 | AlogP: 2.29 | #Rotatable Bonds: 5 |
| Polar Surface Area: 98.05 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.38 | CX LogP: 1.53 | CX LogD: 1.53 |
| Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.73 | Np Likeness Score: -1.47 |
References
| 1. Klöck C, Herrera Z, Albertelli M, Khosla C.. (2014) Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2., 57 (21): [PMID:25333388] [10.1021/jm501145a] |
Source
Source(1):